Dynamic Urinary Proteomics Integrates Single-Cell and Spatial Transcriptomics to Reveal Tumor Microenvironment and Predict Immunotherapy Response in Biliary Tract Cancer

Scientists established urinary proteomics as a predictive tool for immune checkpoint inhibitor responsiveness and to elucidate its relationship with tumor dynamics and tumor microenvironment remodeling in biliary tract cancer.